Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on first line management of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Jessicca Lin as the primary speaker and Dr. T. Raja, Dr. Amit Rauthan, Dr. B. K. Smruti and many other panelists who will share the important facts associated with first line management of ALK positive lung cancer.
Starting with the case scenario of non-small cell lung cancer, Dr Jessica has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, the panel discussion will give more knowledge.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Mobile prostate cancer screening clinic can ID the disease in disadvantaged men
2.
Clinical trial is testing whether heavy lifting could combat cancer side effects
3.
NIH research cuts leave cancer patient facing hard choice
4.
Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.
5.
A video animation guide to assist young people who are fatigued from cancer.
1.
Hematology Drug Preparation Safety: Ensuring Efficacy and Reducing Risks in Clinical Practice
2.
The Latest Advances in Glioblastoma Treatment and Prevention
3.
AI-Assisted Real-Time Tumor Mapping During Surgery: Transforming Intraoperative Oncology
4.
Optimizing Platelet Transfusions: Balancing Benefits and Risks in Modern Hematology
5.
Decoding the Failures in Acute Myeloid Leukemia Treatment: Mechanisms, Pathways, & Survival Outcomes
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation